Advancing the frontiers of structural and interventional cardiology — from cardiogenic shock and mechanical circulatory support to next-generation valve therapies and complex coronary intervention.
A comprehensive subspecialty practice spanning the full spectrum of structural and interventional cardiovascular care.
Transcatheter aortic valve replacement (SAPIEN), MitraClip mitral TEER, Evoque tricuspid valve replacement, TMVR, PFO/ASD closure, and Watchman LAA occlusion.
Expert management of cardiogenic shock with Impella (CP, 5.5), VA-ECMO, intra-aortic balloon pump, and percutaneous mechanical circulatory support strategies for high-acuity patients.
IVUS and OCT-guided PCI, rotational atherectomy, left main and CTO intervention, bifurcation techniques, and physiologic assessment with FFR/iFR for optimal revascularization.
Lipid management, cardiovascular risk reduction, subclinical atherosclerosis, and translating the latest trials and guideline updates into clinical practice and medical education.
Dr. Ali Akram Khan is an interventional and structural cardiologist currently serving as Chief Structural Cardiology Fellow and Junior Faculty Attending at NYU Langone Health, New York. He completed his Interventional Cardiology Fellowship at McLaren Regional Hospital (Chief Fellow) and his Cardiovascular Disease Fellowship at McLaren Flint (Chief Fellow), followed by Internal Medicine Residency at Detroit Medical Center / Wayne State University.
His structural heart practice spans the full spectrum of transcatheter valve therapies — including TAVR, TMVR, TTVR, mitral and tricuspid transcatheter edge-to-edge repair, paravalvular leak closures, PFO/ASD closures, and left atrial appendage occlusion — alongside expert management of cardiogenic shock with percutaneous mechanical circulatory support and complex high-risk coronary intervention.
Dr. Khan has served as Clinical Instructor at Michigan State University College of Medicine and Visiting Professor at Central Park Medical College, Lahore. He is a passionate advocate for cardiovascular education through social media and medical community engagement.
He is available for speaking engagements, podcast appearances, media commentary, and industry education partnerships.
Podcast guest appearances, conference presentations, and media commentary. More being added as appearances are confirmed.
In-depth discussion on advanced structural heart procedures and mechanical circulatory support strategies for high-risk patients.
Visit CardioNerdsInterview covering the journey from Pakistan to interventional and structural cardiology in New York, the evolving landscape of structural heart disease, and the importance of mentorship and diversity in medicine.
Watch on YouTubeCase-based presentations on complex coronary intervention, IVUS-guided PCI, and next-generation valve therapies at national cardiology meetings.
TCTMD.comEducational content on complex heart procedures, cardiovascular risk, and the latest clinical trials — made accessible for patients and physicians alike.
Follow on TikTokSelected cardiology publications. Full list on Google Scholar.
A comprehensive cardiology education platform — guidelines, late-breaking trials, complex cases, clinical pearls, and procedural videos. Updated continuously.
Available for podcast interviews, conference speaking, medical education partnerships, industry faculty programs, and media commentary on cardiovascular topics.
Your message has been received. Dr. Khan's team will review your inquiry and respond within 24 hours. For urgent matters, connect directly on LinkedIn.
Dr. Khan sees patients for structural heart disease, complex coronary disease, cardiogenic shock, and second opinions. Submit your information and Dr. Khan's team will be in touch to arrange a consultation.
Thank you for reaching out. Your information has been submitted and Dr. Khan's team will contact you within 2–3 business days to discuss next steps and scheduling. Please do not submit duplicate requests.
Follow Dr. Khan
Follow along for cardiology education, clinical commentary, and the latest in structural and interventional heart disease.